Evidence map›Paper›PMID 28842504›Full record

ArticleThe Journal of biological chemistry2017

Functional defects in

Pulkit Gupta, Zhifen Zhang, Seiji N Sugiman-Marangos, John Tam, Swetha Raman, Jean-Phillipe Julien, Heather K Kroh, D Borden Lacy, Nicholas Murgolo, Kavitha Bekkari and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Clostridioides difficile pathogenesis and control.Nature reviews. Microbiology · 2026
    Review
  2. Mouse monoclonal antibodies againstInfection and immunity · 2025
    Article
  3. Review
  4. De novo design of potent inhibitors of clostridial family toxins.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Community-AcquiredInternational journal of molecular sciences · 2025
    Review
  6. MappingmBio · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Large Clostridial Toxins: Mechanisms and Roles in Disease.Microbiology and molecular biology reviews : MMBR · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Pulkit GuptaFrom Merck & Co., Inc., Kenilworth, New Jersey 07033.
Zhifen ZhangMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada.
Seiji N Sugiman-MarangosMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada.
John TamMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada.
Swetha RamanMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada.
Jean-Phillipe JulienMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada.
Heather K Krohthe Departments of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37212.
D Borden Lacythe Departments of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37212.
Nicholas MurgoloFrom Merck & Co., Inc., Kenilworth, New Jersey 07033.
Kavitha BekkariFrom Merck & Co., Inc., Kenilworth, New Jersey 07033.
Alex G TherienFrom Merck & Co., Inc., Kenilworth, New Jersey 07033.
Lorraine D HernandezFrom Merck & Co., Inc., Kenilworth, New Jersey 07033.
Roman A MelnykMolecular Medicine, The Hospital for Sick Children, Ontario M5G 0A4, Canada, roman.melnyk@sickkids.ca.
Hospital for Sick Children · CAMerck & Co., Inc., Rahway, NJ, USA (United States) · USVanderbilt University · USUniversity of Toronto · CA

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Structural mechanisms of Clostridium difficile pathogenesisR01AI095755 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LACY, DANA BORDEN · 2011 to 2020
$3.9M
Structural Mechanisms of Clostridioides difficile pathogenesisR37AI095755 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Dana Borden Lacy · 2021 to 2026
$3.2M
The role of toxins in Clostridium difficile infection pathogenesisI01BX002943 · VA · VETERANS HEALTH ADMINISTRATION · PI LACY, DANA BORDEN · 2016 to 2025
–
BLRD VA I01 BX002943CIHRNIAID NIH HHS R37 AI095755NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingBacterial ProteinsBacterial ToxinsBroadly Neutralizing AntibodiesCaco-2 CellsChlorocebus aethiopsCHO CellsChondroitin Sulfate Proteoglycan 4Chondroitin Sulfate ProteoglycansClostridioides difficileCricetinaeCricetulusGlucosyltransferasesHEK293 CellsAntibodies, MonoclonalAntibodies, NeutralizingBacterial ProteinsBacterial ToxinsbezlotoxumabBroadly Neutralizing AntibodiesChondroitin Sulfate Proteoglycan 4Chondroitin Sulfate ProteoglycansCSPG4 protein, humanGlucosyltransferasesMembrane ProteinstoxB protein, Clostridium difficileantibodycell surfacereceptortoxintrafficking

Identifiers

PMID28842504
PMCPMC5655507
OpenAlexW2746939497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.